Table 3:

Comparison of predicted post-transplant survival for 5 sample patients transplanted for HCC within Milan criteria

Age at transplant	71	70	65	67	54
Pre-transplant CKD	Yes	No	No	No	No
Total bilirubin	0.6	2.6	3.3	0.5	0.5
INR	1.0	1.8	1.4	1.3	1.1
eGFR, mL/min/1.73m2	55	47.5	115	76	76.0
Diabetes	Yes	Yes	No	No	No
Location	Home	Home	Home	Home	Home
Etiology of liver disease	NASH	NASH	HCV	HBV	HBV
Ventilated	No	No	No	No	No
AFP at listing	91	19	39	4	11
AFP at transplant	224	20	11	7	14
Total tumor diameter at listing	4.5	4.3	2.9	2.1	2.9
Total tumor diameter at transplant	3.7	4.9	1.5	2.1	2.9
LiTES Score†	14.2	19.7	27.9	38.2	52.7
Predicted post-transplant survival time based on LiTES
5-year time horizon	4.07	4.17	4.34	4.50	4.66
10-year time horizon	6.80	7.14	7.63	8.16	8.72

Abbreviations: eGFR=estimate glomerular filtration rate

^*Tumor size based on center to OPTN/UNOS and decreased sizes reflect changes from loco-regional therapy

^†LiTES score calculated based on coefficients from Table 1, with predicted survival time based on based on the survival curves developed in the validation cohort.